Spiral Therapeutics is a clinical-stage company focused on delivering therapies for inner ear disorders. Spiral's novel drug delivery platform allows for minimally invasive, precise and durable exposure of drugs to the cochlea. Spiral is advancing a therapeutic pipeline with focus on hearing loss and balance disorders. Spiral's lead program, SPT-2101, is a sustained-release steroid formulation for the treatment of inner ear inflammation.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/30/23 | undisclosed |
Esperante Ferring Ventures | undisclosed |
